Jay Naik
-
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 3
- CAR-T cell therapy research 2
-
- Virus-based gene therapy research 2
- Genomics and Rare Diseases 1
-
- Advanced Breast Cancer Therapies 2
-
- Nausea and vomiting management 1
- Testicular diseases and treatments 1
- Co-authors
- Peter J. SelbyJohn ChesterRichard G. VileTimothy PerrenJenny F. SeligmannChristopher TwelvesAndrew W. HudacekAlan Melcher
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Jay Naik
12 papers receiving 179 citations
Peers
Comparison fields: 5 of 46
- Oncology 108
- Genetics 101
- Reproductive Medicine 22
- Biotechnology 20
- Animal Science and Zoology 14
Countries citing papers authored by Jay Naik
This map shows the geographic impact of Jay Naik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Naik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Naik more than expected).
Fields of papers citing papers by Jay Naik
This network shows the impact of papers produced by Jay Naik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Naik. The network helps show where Jay Naik may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jay Naik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 3 | |
| 4 | 2018 | 13 | |
| 5 | 2017 | 2 | |
| 6 | Effects of perioperative lapatinib and trastuzumab, alone and in combination, in early HER2+breast cancer - the UK EPHOS-B trial (CRUK/08/002) | 2016 | 4 |
| 7 | 2016 | 2 | |
| 8 | 2012 | 8 | |
| 9 | 2011 | 22 | |
| 10 | 2011 | 31 | |
| 11 | 2008 | 76 | |
| 12 | 2008 | 16 | |
| 13 | 2006 | 2 |
About Jay Naik
Jay Naik is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Clinical Biochemistry, having authored 13 papers that have together received 181 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), HER2/EGFR in Cancer Research (3 papers), Virus-based gene therapy research (2 papers), Advanced Breast Cancer Therapies (2 papers), CAR-T cell therapy research (2 papers), Nausea and vomiting management (1 paper), Genomics and Rare Diseases (1 paper) and Testicular diseases and treatments (1 paper). The work is most often cited by research in Oncology (108 citations), Genetics (101 citations) and Reproductive Medicine (22 citations). Jay Naik has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Peter J. Selby, John Chester, Richard G. Vile, Timothy Perren, Jenny F. Seligmann, Christopher Twelves, Andrew W. Hudacek, Alan Melcher, John C. Bell and Jill Thompson. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.